- Home
- APCX vs NKGN Comparison
APCX vs NKGN Comparison
Compare APCX & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APCX
- NKGN
- Stock Information
- Founded
- APCX 2006
- NKGN 2017
- Country
- APCX United States
- NKGN United States
- Employees
- APCX N/A
- NKGN N/A
- Industry
- APCX Finance: Consumer Services
- NKGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- APCX Finance
- NKGN Health Care
- Exchange
- APCX Nasdaq
- NKGN Nasdaq
- Market Cap
- APCX N/A
- NKGN 14.1M
- IPO Year
- APCX N/A
- NKGN N/A
- Fundamental
- Price
- APCX $0.60
- NKGN $0.65
- Analyst Decision
- APCX
- NKGN
- Analyst Count
- APCX 0
- NKGN 0
- Target Price
- APCX N/A
- NKGN N/A
- AVG Volume (30 Days)
- APCX 10.7M
- NKGN 573.1K
- Earning Date
- APCX 11-14-2024
- NKGN 12-31-2024
- Dividend Yield
- APCX N/A
- NKGN N/A
- EPS Growth
- APCX N/A
- NKGN N/A
- EPS
- APCX N/A
- NKGN N/A
- Revenue
- APCX $365,000.00
- NKGN N/A
- Revenue This Year
- APCX $1,315.48
- NKGN N/A
- Revenue Next Year
- APCX N/A
- NKGN N/A
- P/E Ratio
- APCX N/A
- NKGN N/A
- Revenue Growth
- APCX N/A
- NKGN N/A
- 52 Week Low
- APCX $0.31
- NKGN $0.20
- 52 Week High
- APCX $2.30
- NKGN $4.06
- Technical
- Relative Strength Index (RSI)
- APCX 60.21
- NKGN 65.93
- Support Level
- APCX $0.36
- NKGN $0.45
- Resistance Level
- APCX $1.49
- NKGN $0.62
- Average True Range (ATR)
- APCX 0.14
- NKGN 0.08
- MACD
- APCX 0.02
- NKGN 0.01
- Stochastic Oscillator
- APCX 24.32
- NKGN 70.95
About NKGN NKGen Biotech Inc.
NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.